Jefferies Financial Group Inc. lessened its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 45.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 9,615 shares of the company’s stock after selling 7,981 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Clorox were worth $969,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently bought and sold shares of the business. Center for Financial Planning Inc. purchased a new position in shares of Clorox in the third quarter valued at $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of Clorox in the third quarter valued at $25,000. Darwin Wealth Management LLC purchased a new position in shares of Clorox in the second quarter valued at $29,000. Vision Financial Markets LLC increased its position in shares of Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares in the last quarter. Finally, Ameriflex Group Inc. increased its position in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after buying an additional 273 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the company. Rothschild & Co Redburn set a $117.00 price target on Clorox in a research report on Friday, February 13th. Barclays decreased their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Morgan Stanley decreased their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Wells Fargo & Company decreased their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Finally, UBS Group decreased their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $103.40.
Clorox Stock Performance
Clorox stock opened at $96.19 on Friday. The stock’s 50-day moving average is $98.82 and its 200-day moving average is $105.92. The company has a market cap of $11.63 billion, a price-to-earnings ratio of 15.62, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s quarterly revenue was up .1% compared to the same quarter last year. During the same period last year, the business posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.
Insider Activity at Clorox
In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is currently owned by company insiders.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
